Clinical Trials Sponsored by European Egyptian Pharmaceutical Industries

Total 5 results

European Egyptian Pharmaceutical Industries

Completed

Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment (PEDFUT)

Diabetic Foot Ulcer

Egypt
European Egyptian Pharmaceutical Industries

Terminated

Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (PED111)

Diabetic Foot Ulcer

Egypt
Genuine Research Center, Egypt
European Egyptian Pharmaceutical Industries

Completed

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

Healthy

Egypt
Genuine Research Center, Egypt
European Egyptian Pharmaceutical Industries

Completed

Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)

Healthy

Egypt
University of Southampton
NIHR Clinical Research Facility, University Hospital Southampton NHS Foundation... and other collaborators

Terminated

High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant (AntiCD-66)

Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom

3

Subscribe